• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纳米混悬液制剂对难溶性药物的转运、药代动力学、体内靶向性及疗效的影响。

Effects of nanosuspension formulations on transport, pharmacokinetics, in vivo targeting and efficacy for poorly water-soluble drugs.

作者信息

Wang Yancai, Miao Xiaoqing, Sun Lin, Song Ju, Bi Chao, Yang Xiao, Zheng Ying

机构信息

Institute of Chinese Medical Sciences, University of Macau, 3/F, Rm 204A, Block 3, Av. Padre Tomás Pereira, S.J. Taipa, Macao SAR, China.

出版信息

Curr Pharm Des. 2014;20(3):454-73. doi: 10.2174/13816128113199990403.

DOI:10.2174/13816128113199990403
PMID:23651402
Abstract

A surprisingly large proportion of new chemical entities (NCE) is emerging from the drug discovery pipeline, and many active components extracted from herbal medicines are water insoluble, which represents a great challenge for their development. Nanosuspensions, which are submicron colloidal dispersions of pure drug particles that are stabilised by a small percentage of the excipients, could dramatically enhance the saturated solubility, dissolution rate and adhesion of drug particles to cell membranes. Nanosuspensions are the most suitable for drugs that require high dosing or have limited administrative volume. After 20 years of development, several oral products and one injectable product are commercially available. The aim of this review is to fill the gap between rational formulation designs and the in vivo performance of poorly water-soluble drug nanosuspensions. Specifically, this review will correlate characteristics of nanosuspension formulations, including drug property, particle size, crystallinity, stabiliser and surface property, with their transport, pharmacokinetics, bioactivity and toxicity after delivery by different administration routes. The elucidation of the mechanisms of targeted drug delivery, cellular transport and internalisation of nanosuspensions are also reviewed to interpret the in vivo performance of these nanosuspensions. Moreover, the recent application of nanosuspensions for poorly water-soluble herbal medicines is highlighted.

摘要

新药研发流程中涌现出的新化学实体(NCE)比例高得出奇,并且许多从草药中提取的活性成分难溶于水,这对其开发而言是巨大挑战。纳米混悬液是由少量辅料稳定的纯药物颗粒的亚微米胶体分散体,可显著提高药物颗粒的饱和溶解度、溶解速率以及与细胞膜的黏附性。纳米混悬液最适用于需要高剂量给药或给药体积受限的药物。经过20年的发展,已有几种口服产品和一种注射产品上市。本综述的目的是填补难溶性药物纳米混悬液合理剂型设计与体内性能之间的空白。具体而言,本综述将纳米混悬液剂型的特性(包括药物性质、粒径、结晶度、稳定剂和表面性质)与其通过不同给药途径给药后的转运、药代动力学、生物活性和毒性联系起来。还综述了纳米混悬液靶向给药、细胞转运和内化机制的阐释,以解读这些纳米混悬液的体内性能。此外,还重点介绍了纳米混悬液在难溶性草药中的最新应用。

相似文献

1
Effects of nanosuspension formulations on transport, pharmacokinetics, in vivo targeting and efficacy for poorly water-soluble drugs.纳米混悬液制剂对难溶性药物的转运、药代动力学、体内靶向性及疗效的影响。
Curr Pharm Des. 2014;20(3):454-73. doi: 10.2174/13816128113199990403.
2
Nanosuspensions of poorly water soluble drugs prepared by top-down technologies.通过自上而下技术制备的难溶性药物纳米混悬剂。
Curr Pharm Des. 2014;20(3):388-407. doi: 10.2174/13816128113199990401.
3
Practical method for preparing nanosuspension formulations for toxicology studies in the discovery stage: formulation optimization and in vitro/in vivo evaluation of nanosized poorly water-soluble compounds.发现阶段毒理学研究纳米混悬剂制剂的实用制备方法:纳米级难溶性化合物的制剂优化及体外/体内评价
Chem Pharm Bull (Tokyo). 2014;62(11):1073-82. doi: 10.1248/cpb.c14-00232.
4
Nanosuspensions of poorly water-soluble drugs prepared by bottom-up technologies.通过自下而上技术制备的难溶性药物纳米混悬液。
Int J Pharm. 2015 Nov 30;495(2):738-49. doi: 10.1016/j.ijpharm.2015.09.021. Epub 2015 Sep 14.
5
Nanosuspensions in drug delivery: recent advances, patent scenarios, and commercialization aspects.纳米混悬剂在药物传递中的应用:最新进展、专利现状及商业化方面。
Crit Rev Ther Drug Carrier Syst. 2011;28(5):447-88. doi: 10.1615/critrevtherdrugcarriersyst.v28.i5.20.
6
Formulation aspects of intravenous nanosuspensions.静脉注射用纳米混悬剂的制剂方面。
Int J Pharm. 2020 Aug 30;586:119555. doi: 10.1016/j.ijpharm.2020.119555. Epub 2020 Jun 17.
7
Drug nanosuspensions: a ZIP tool between traditional and innovative pharmaceutical formulations.药物纳米混悬剂:传统与创新药物制剂之间的 ZIP 工具。
Expert Opin Drug Deliv. 2015;12(10):1607-25. doi: 10.1517/17425247.2015.1043886. Epub 2015 May 10.
8
Production of nanosuspensions as a tool to improve drug bioavailability: focus on topical delivery.纳米混悬剂作为提高药物生物利用度的工具:聚焦于局部给药
Curr Pharm Des. 2015;21(42):6089-103. doi: 10.2174/1381612821666151027152350.
9
Solution calorimetry as an alternative approach for dissolution testing of nanosuspensions.溶液热分析法作为纳米混悬剂溶出试验的替代方法。
Eur J Pharm Biopharm. 2010 Nov;76(3):507-13. doi: 10.1016/j.ejpb.2010.09.009. Epub 2010 Sep 29.
10
Mucus-Penetrating Nanosuspensions for Enhanced Delivery of Poorly Soluble Drugs to Mucosal Surfaces.用于增强难溶性药物向粘膜表面递送的粘液穿透纳米混悬液。
Adv Healthc Mater. 2016 Nov;5(21):2745-2750. doi: 10.1002/adhm.201600599. Epub 2016 Sep 26.

引用本文的文献

1
The effect of surface treatment on the brain delivery of curcumin nanosuspension: in vitro and in vivo studies.表面处理对姜黄素纳米混悬液脑内递药的影响:体内外研究。
Int J Nanomedicine. 2019 Jul 19;14:5477-5490. doi: 10.2147/IJN.S199624. eCollection 2019.
2
Mechanical and aesthetics compatibility of Brazilian red propolis micellar nanocomposite as a cavity cleaning agent.巴西红蜂胶胶束纳米复合材料作为腔清洁剂的机械和美学相容性。
BMC Complement Altern Med. 2018 Jul 18;18(1):219. doi: 10.1186/s12906-018-2281-y.